We are live on ! Find out more
FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of FUSN yet.

FUSN Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q2 2024, worth a combined $0 — down 100% from $1.47B a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of FUSN and 0 opened new positions — a net loss of 112 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Federated Hermes, exiting entirely with an estimated $230M sold.

  • 0 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q2 2024, down from 114 in Q1 2024.
  • Funds reported $0 of Fusion Pharmaceuticals Inc. Common Shares stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q2 2024 and 112 closed out, a net change of -112 holders.
  • The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q2 2024 was Federated Hermes, an estimated $230M sold.

Based on aggregated 13F filings for Q2 2024.